|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 701 PENNSYLVANIA AVENUE, N.W., SUITE 800 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 17831-12
|
||||||||
|
6. House ID# 310010000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Juan Carlos Scott, Senior Executive Vice President and Director, Government Affiars |
Date | 01/18/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to oversight of implantable devices [Elizabeth Kegler, JC Scott]
H.R. 675-- Strengthening Medicare Anti-Fraud Measures Act of 2011. [Elizabeth Kegler]
Issues related to the implementation of Section 6002 (Transparency Reports and Reporting of Physician Ownership or Investment Interests) of the Patient Protection and Affordable Care Act (PL 111-148). [Elizabeth Kegler, Elizabeth Sharp]
Issues related to physician owned distributors of devices [Elizabeth Kegler]
S. 668/HR Health Care Bureaucrats Elimination Act (Repeal of IPAB). [Elizabeth Kegler, JC Scott]
H.R. 452 Medicare Decisions Accountability Act of 2011(Repeal of IPAB). [Elizabeth Kegler, , JC Scott]
H.R. 3497 Modernizing Our Drug & Diagnostics Evaluation and Regulatory Network Cures Act of 2011 (Payment Reform) [Duane Wright, Elizabeth Sharp, Elizabeth Kegler, JC Scott]
H.R. 6446 To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests. [Duane Wright, Elizabeth Sharp, Elizabeth Kegler]
Issues related to deficit reduction and Medicare [Elizabeth Sharp, Elizabeth Kegler, JC Scott, Duane Wright]
Issues related to gainsharing [Elizabeth Kegler, Duane Wright]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
JC |
Scott |
|
|
|
Elizabeth |
Kegler |
|
|
|
Elizabeth |
Sharp |
|
|
|
Duane |
Wright |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to implementation of PL 112-144, the Food and Drug Administration Safety and Innovation Act [Elizabeth Sharp, JC Scott, Elizabeth Kegler]
Issues related to the medical device user fee program [Elizabeth Sharp, Elizabeth Kegler, JC Scott]
Sen. Orrin Hatch draft BETTER Patient Care Act. To restructure how the FDA regulates certain advanced diagnostics [JC Scott, Duane Wright, Elizabeth Kegler]
Issues related to the competitiveness of the medical technology industry and the impact of Federal policies. [Elizabeth Sharp, Elizabeth Kegler, JC Scott]
Issues related to diagnostics regulation [Elizabeth Sharp, Elizabeth Kegler, JC Scott, Duane Wright]
Issues related to the definition of durable for durable medical equipment [Duane Wright]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
JC |
Scott |
|
|
|
Elizabeth |
Kegler |
|
|
|
Elizabeth |
Sharp |
|
|
|
Duane |
Wright |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues relating to FY13 funding for the Food and Drug Administration [Elizabeth Sharp, JC Scott, Elizabeth Kegler]
H.J.Res. 117 Continuing Appropriations Resolution 2013 [Elizabeth Sharp, JC Scott, Elizabeth Kegler]
H.R. 8 American Taxpayer Relief Act of 2012 [Elizabeth Sharp, Elizabeth Kegler, JC Scott, Duane Wright]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Sharp |
|
|
|
Elizabeth |
Kegler |
|
|
|
JC |
Scott |
|
|
|
Duane |
Wright |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 17, S. 262, HR 436, HR 488, HR 734 bills related to the Medical Device Excise Tax [Elizabeth Kegler, Elizabeth Sharp, JC Scott, Duane Wright]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Kegler |
|
|
|
Elizabeth |
Sharp |
|
|
|
JC |
Scott |
|
|
|
Duane |
Wright |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |